ARTICLES BY LIISA VEXLER
-
Age-Appropriate Doses and Formulations For The Elderly May Bolster Smarter Prescribing Habits4/9/2014
Clinical trials using elderly patient participants are few and far between, despite the elderly being the fastest-growing portion of the world’s population.
-
South Korean Pharma Sector To Reach $24 Billion Value By 20204/9/2014
The pharmaceutical industry in South Korea will continue to grow over the next six years, from $19.3 billion in 2013 to an anticipated $24.3 billion by 2020 says GlobalData, a research and consulting company.
-
Why Generix (GNBT), Valeant (VRX) And Orexigen (OREX) Looking Good3/4/2014
In the latest trade session, Generex Biotechnology Corporation (OTCMKTS:GNBT) hit an intraday high level of $0.04. A recent release from GNTB shows that results of an interim analysis study of a vaccine designed to prevent a relapse in breast cancer patients has been reinforced by a Phase II study.
-
Canadian Biopharmaceutical Company Announces $52 Million Financing For Anti-Lupus Drug2/21/2014
Aurinia Pharmaceuticals, based in Victoria, has raised the record amount of US$52 million for clinical and nonclinical development of voclosporin as treatment for lupus nephritis, an autoimmune disease that affects the kidneys. Some of the funds will be used for the company's operating expenses.
-
New Report Predicts Major Changes in Latin American Market for Diabetes2/21/2014
According to a new report published by Frost & Sullivan, the Latin American market for diabetes medication will undergo major changes over the next three years.